Qiagen NV at Citi Healthcare & Medtech Conference Transcript
All right. Well, thank you, everybody, for joining us. I'm Patrick Donnelly, the tools and diagnostics analyst here. We have Thierry Bernard, the CEO of QIAGEN. He is virtual today, scheduled to be here, but wasn't able to make it. So we do -- we have him on the Zoom here. So Thierry, thanks for joining us. Thanks for being here in a virtual setting at least.
Thanks for the invitation. And I apologize for not being able to be with you in New York, sincere apologies, yes.
Questions & Answers
Not a problem. So maybe we can start just fresh off 4Q. I know a lot of the companies are just kind of rehashing what happened there to start things off. You guys reported a pretty clean beat, kind of gave the initial '23 guidance. But maybe we can start just talking through some of the moving
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |